CNS Pharmaceuticals, Inc. - CNSP
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$651K
QoQ value delta ($000)
+$431K
(+195.91%)
Implied price effect (QoQ)
-41.38%
Shares
Total shares
124,253
QoQ shares delta
+99,637
(+404.77%)
Total shares held by funds (by quarter)
Market chart (CNSP)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 12 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Stonepine Capital Management, LLC | 256 | 48,827 | 0.19% |
| Ikarian Capital, LLC | 240 | 45,830 | 0.02% |
| DRW Securities, LLC | 81 | 15,429 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 71 | 13,524 | 0.0% |
| UBS Group AG | 3 | 611 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 4 | 0.0% |
| DANSKE BANK A/S | 0 | 1 | 0.0% |
| BARRETT & COMPANY, INC. | 0 | 8 | 0.0% |
| MAI Capital Management | 0 | 3 | 0.0% |
| Sound Income Strategies, LLC | 0 | 16 | 0.0% |